Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
Published Mar 15, 2005 · D. D’Souza, W. Abi-Saab, S. Madonick
Biological Psychiatry
585
Citations
21
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayDelta-9-tetrahydrocannabinol (Delta-9-THC) transiently exacerbates core psychotic and cognitive deficits in schizophrenia patients, with schizophrenia patients being more vulnerable to its effects.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.